Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04251676

Enrollment

200

Registered

2020-02-05

Start date

2010-01-01

Completion date

2021-12-01

Last updated

2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Brief summary

We wish to study radiation therapy in uterine cancer, focusing on dosimetry analysis, clinical implication, and survival analysis.

Detailed description

We wish to study radiation therapy in uterine cancer, focusing on dosimetry analysis, clinical implication, and survival analysis.

Interventions

OTHERObservational study

Observational study

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Women with uterine cancer (stage I - IV) treated in National Taiwan University Hospital, from January 2010 to September 2019.

Exclusion criteria

* Women with uterine cancer (stage I - IV) NOT treated in National Taiwan University Hospital, from January 2010 to September 2019.

Design outcomes

Primary

Measure	Time frame	Description
Progression free survival	5 years	Progression free survival: The time from inclusion to documented disease progression according to RECIST v1.1 or death from any cause.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026